Daugaard Henrik
Department of Orthopaedics, Aarhus University Hospital, Denmark.
Dan Med Bull. 2011 Sep;58(9):B4317.
Primary joint replacements generally function well with excellent clinical results. However, failure rates for young patients are still high and increasing in number. The longterm survival of an uncemented prosthesis is influenced by multiple factors depending on host physiology as well as properties of implanted material, initial mechanical stability, early osseointegration, and the surrounding bone. Parathyroid hormone is the principal regulator of calcium homeostasis and involved in the control of bone remodelling. Parathyroid hormone administered intermittently increases bone formation and mass by osteoblast stimulation. Early osseointegration and implant fixation could potentially be enhanced with adjuvant parathyroid hormone treatment. The aim of the studies in this PhD thesis was to determine if implant fixation of experimental implants can be improved with adjuvant intermittent administration of parathyroid hormone.
All studies used an experimental canine model of early implant fixation inserting porous coated titanium alloy implants with no weight bearing in a bed of cancellous bone. The study design was un-paired. Test animals were randomised to PTH (1-34) 5 μm/kg daily for 4 weeks. Implant fixation was defined by mechanical stability and osseointegration. Study I investigated the effect of parathyroid hormone on implant fixation of implants inserted press fit with surrounding bone in the proximal tibia of 20 canines. Histomorphometric analysis showed increased amount of new bone in contact with the implant. No improvement was observed in the surrounding bone. PTH did not increase mechanical fixation in pushout test. Study II investigated the effect of parathyroid hormone on implant fixation of implants surrounded by a critical 1 mm gap. Implants where inserted in the tibia of 20 canines. Bone density was increased in the inner gap and outer gap with PTH treatment. Bone at implant interface improved with PTH but did not achieve significance. Push-out testing showed that PTH Increased mechanical implant fixation in shear stiffness and total energy absorption. Shear strength was not significantly increased. Study III investigated the effect on implant fixation of implants surrounded by a 2.5 mm gap in which morsellised allograft was impacted. Implants were inserted in 20 Canines in the humerus. Histomorphometric analysis showed that PTH increased the amount of new bone within the gap, but not in contact the implant. There were no differences in amount of allograft. The push-out testing showed no differences in mechanical parameters.
The studies in this PhD thesis demonstrated that parathyroid hormone increases bone healing around implants in situations of insertion in press-fit or in more challenging environments of empty and grafted gaps. Early fixation was increased in implants with gaps, in which pure gap bone stimulation improved fixation. This warrants further preclinical studies.
初次关节置换术通常效果良好,临床结果优异。然而,年轻患者的失败率仍然很高且呈上升趋势。非骨水泥假体的长期存活受多种因素影响,这些因素取决于宿主生理状况以及植入材料的特性、初始机械稳定性、早期骨整合和周围骨骼情况。甲状旁腺激素是钙稳态的主要调节因子,参与骨重塑的控制。间歇性给予甲状旁腺激素可通过刺激成骨细胞增加骨形成和骨量。辅助使用甲状旁腺激素治疗可能会增强早期骨整合和植入物固定。本博士论文中各项研究的目的是确定辅助间歇性给予甲状旁腺激素是否能改善实验性植入物的固定。
所有研究均使用早期植入物固定的实验犬模型,将多孔涂层钛合金植入物插入松质骨床中,且不负重。研究设计为非配对。将实验动物随机分为两组,一组每天给予甲状旁腺激素(1-34)5μg/kg,持续4周。植入物固定通过机械稳定性和骨整合来定义。研究I调查了甲状旁腺激素对20只犬胫骨近端与周围骨压配植入的植入物固定的影响。组织形态计量学分析显示与植入物接触的新骨量增加。周围骨未见改善。在推出试验中,甲状旁腺激素未增加机械固定。研究II调查了甲状旁腺激素对周围有1mm关键间隙的植入物固定的影响。将植入物插入20只犬的胫骨中。甲状旁腺激素治疗使内部间隙和外部间隙的骨密度增加。植入物界面处的骨有改善,但未达显著水平。推出试验表明,甲状旁腺激素增加了植入物在剪切刚度和总能量吸收方面的机械固定。剪切强度未显著增加。研究III调查了对周围有2.5mm间隙且植入碎骨同种异体骨的植入物固定的影响。将植入物插入20只犬的肱骨中。组织形态计量学分析表明,甲状旁腺激素增加了间隙内的新骨量,但与植入物接触处未增加。同种异体骨量无差异。推出试验显示机械参数无差异。
本博士论文中的研究表明,甲状旁腺激素在压配植入或在更具挑战性的空间隙和植入移植物间隙环境中,可增加植入物周围的骨愈合。在有间隙的植入物中早期固定增加,其中单纯间隙骨刺激改善了固定。这值得进一步的临床前研究。